Scientists create successful mass production system for bioengineered liversDecember 05, 2017
CINCINNATI - Researchers report creating a biologically accurate mass-production platform that overcomes major barriers to bioengineering human liver tissues suitable for therapeutic transplant into people.
A team led by the Cincinnati Children's Center for Stem Cell and Organoid Medicine (CuSTOM) and Yokohama City University in Japan report their findings Dec. 5 in Cell Reports. The study's lead investigator is Takanori Takebe, MD, a physician/investigator at both institutions.
The current study overcomes what have been nagging challenges for researchers working to bioengineer human organs that are safe and effective for therapeutic use, according to Takebe.
The new process allows researchers to bioengineer single batches of up to 20,000 genetically matched, three-dimensional and highly functional liver micro-buds. When combined, the batch has a sufficient quantity of liver cells and size feasibility for transplant into a person with liver failure, or for drug testing. The liver tissues were also generated entirely from human induced pluripotent stem cells (iPSCs), making the process free of animal feeder byproducts used to make cells for research purposes - a barrier to the cells being used therapeutically.
"Because we can now overcome these obstacles to generate highly functional, three-dimensional liver buds, our production process comes very close to complying with clinical-grade standards," explains Takebe. "The ability to do this will eventually allow us to help many people with final-stage liver disease. We want to save the lives of children who need liver transplants by overcoming the shortage of donor livers available for this."
The researchers stress continued research and refinement of their process is required before initial clinical trials could begin. Takebe estimates this might occur in the next two to five years.
Liver by Design
The work includes an international team of scientific and industrial collaborators, mostly in Japan and in Cincinnati. Takebe and colleagues over the past five years published several studies that made continuous progress into defining the precise genetic and molecular blueprints needed to mimic natural human development. This allows the researchers to develop and bioengineer functional, three-dimensional human mini livers in the laboratory.
To help overcome the biological challenge of animal-product feeder cells in the current study, Takebe and team used their fine-tuned formula of genetic and molecular components to generate the liver tissues in custom-designed, U-shaped bottom micro-well cell plates. The plates use a combination of chemistry techniques to form a finely structured film inside the micro-wells, designed to nurture the developing liver buds.
But prior to this step, the researchers started mass production by initially using the donor-derived iPSCs to grow three critical types of liver progenitor cells needed to generate healthy livers. These include hepatic endoderm cells and both endothelial and septum mesenchyme cells. Study data show this generates robust and highly functional progenitor cells that are placed into the custom-designed, film-coated micro-wells. The progenitor cells then engage in high levels of molecular cross-communication to form into self-organizing, three-dimensional liver buds.
The authors write that after they generated over 20,000 (liver) micro spots per well capable of reaching a scalable, therapeutically viable level, they tested the functionality of the three-dimensional tissues in genetically programmed mouse models of liver disease. The animals were rescued from liver disease by the highly functional organs.
Among the many key collaborators on the study is co-author Hideki Taniguchi, MD, PhD, professor, Department of Regenerative Medicine at Yokohama City University.
Designed and manufacture of the Elplasia custom micro well plate involved a collaboration with Kuraray Co., Ltd., in Japan.
Funding support for the research and development came in part from the Research Center Network Grant for Realization of Regenerative Medicine (Japan Agency for Medical Research and Development), PRESTO (Japan Science and Technology Agency), Grantsin-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (24106510, 24689052, 21249071 and 25253079), from the Specified Research Grant of the Takeda Science Foundation and from the Japan IDDM network. Takebe is a New York Stem Cell Foundation - Robertson Investigator.
Takebe and Taniguchi have served on scientific advisory boards for Healios Inc., in Japan, a collaborator on the current study.
Cincinnati Children's Hospital Medical Center
Related Liver Disease Articles:
As the obesity epidemic continues, new data shed light on which nutrients and what quantity of those nutrients promote health or disease.
Researchers have identified the mechanism which causes a build-up of fat in the liver in a disease affecting one in five in the UK -- and were able to reverse it in a mouse model.
New research from Sydney's Westmead Institute for Medical Research highlights the potential for zinc to be used as a simple and effective therapeutic against viral infections such as hepatitis C and influenza.
Patients who undergo the Fontan operation as children for a complex congenital heart defect are at risk of developing progressive liver fibrosis, a buildup of fibrous deposits, as a result of the circulation created by the surgery.
Liver cirrhosis is the 12th leading cause of mortality worldwide and approximately half of those deaths are due to alcohol abuse.
A team of investigators led by Rohit Kohli, MBBS, MS, of Children's Hospital Los Angeles, has identified key inflammatory cells involved in nonalcoholic fatty liver disease.
Nonalcoholic fatty liver disease (NAFLD) -- a condition that can lead to liver cirrhosis and cancer -- isn't typically detected until well advanced.
Non-alcoholic fatty liver disease has become a global epidemic. There is not only a great interest worldwide to understand the causes and consequences of fatty liver disease, but also to diagnose fatty liver disease at an early stage.
EPFL scientists have discovered a new biological mechanism behind nonalcoholic fatty liver disease.
There's new hope for patients with liver disease who are waiting for a donor liver to become available for transplantation.
Related Liver Disease Reading:
The First Year: Cirrhosis: An Essential Guide for the Newly Diagnosed
by James L. Dickerson (Author), Fredric Regenstein (Foreword)
More than 25 million Americans and 92 million worldwide suffer from liver disease and cirrhosis, a degenerative and potentially fatal condition in which liver cells are damaged and then replaced by scar tissue, impeding liver function. The disease is most commonly caused by excessive alcohol consumption, hepatitis, or complications from prescription drugs. Immediately after his diagnosis, James Dickerson set out to educate himself on all of his options — and found there is hope for recovery. Now, he offers The First Year: Cirrhosis, the first guide for patients and their families to... View Details
The Liver Healing Diet: The MD's Nutritional Plan to Eliminate Toxins, Reverse Fatty Liver Disease and Promote Good Health
by Michelle Lai (Author), Asha Kasaraneni (Author)
THE FIRST BOOK TO PROVIDE YOU WITH A DETAILED PROGRAM FOR REVERSING LIVER DAMAGE THROUGH OPTIMAL NUTRITION
The only organ in your body that regenerates itself is the liver. And now, you can make it happen. With a complete program to rejuvenate your liver through optimal nutrition and routine exercise, The Liver Healing Diet shows you how to:
•Improve liver function
•Beat fatty liver disease
•Detoxify the liver
•Boost all-around health
•Nourish the body with delicious recipes
The Liver Healing Diet... View Details
Skinny Liver: A Proven Program to Prevent and Reverse the New Silent Epidemic—Fatty Liver Disease
by Kristin Kirkpatrick (Author), Ibrahim Hanouneh (Author)
Based on the latest research, Skinny Liver is an authoritative, easy-to-follow guide not just for your liver, but for your whole body.
The liver is the seat of our overall health and wellness and the health of nearly every organ is intimately connected with our liver. A healthy liver is essential to a fully functioning body, but our modern sedentary lifestyle and unhealthy eating habits can truly damage the liver--and damage our health overall.
A silent health crisis is impacting one-third of the American population---nonalcoholic fatty liver disease (NAFLD).... View Details
Healing Fatty Liver Disease: A Complete Health and Diet Guide, Including 100 Recipes
by Dr. Maitreyi Raman MD MSc FRCPC (Author), Angela Sirounis BSc RD (Author), Jennifer Shrubsole BSc RD (Author)
Nonalcoholic fatty liver disease (NAFLD) is now the most common cause of chronic liver disease in North America.
Some people with excess fat in the liver simply have what's called a fatty liver. Although this is not normal, it's not serious if it doesn't lead to inflammation or damage. However, once there's a buildup of simple fat, the liver becomes vulnerable to injury which may result in inflammation and scarring of the liver. Others have what's called Nonalcoholic Steatohepatisis (NASH). Although it is similar to alcoholic liver disease, people with this type of... View Details
Schiff's Diseases of the Liver
by Eugene R. Schiff (Editor), Willis C. Maddrey (Editor), K. Rajender Reddy (Editor)
The most important and reliable resource for treating diseases of the liver
For more than 55 years, "Schiff" has been acclaimed as the most outstanding liver book in the world. This new 12th edition brings the field completely up to date and includes a companion website that features a wide-variety of accessory materials. The text is evidence-based to offer hepatologists and gastroenterologists treating patients with liver disease a comprehensive and essential resource. The text highlights clinical practice and covers anatomy, pathology, testing, imaging, and the effects... View Details
Sleisenger and Fordtran's Gastrointestinal and Liver Disease Review and Assessment, 10e
by Emad Qayed MD (Author), Shanthi Srinivasan MD (Author), Nikrad Shahnavaz MD (Author)
For certification and recertification preparation, look no further than the all-new 10th Edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease Review and Assessment. This all-new test preparation book, by Drs. Emad Qayed, Shanthi Srinivasan, and Nikrad Shahnavaz, contains more than 1,000 new single-best-answer multiple-choice questions that test your medical knowledge, clinical reasoning, interpretation, and problem solving skills. Whether used alone or alongside the Sleisenger and Fordtran's Gastrointestinal and Liver Disease text, this review... View Details
What You Must Know About Liver Disease: A Practical Guide to Using Conventional and Complementary Treatments
by Rich Snyder DO (Author)
One of the leading causes of death in the United States, liver disease ranks fourth as a killer of people between the ages of 45 and 64. Unfortunately, without an annual blood test, it can progress silently until the organ’s ability to function has been greatly compromised. When a diagnosis of liver disease is given, the road that lies ahead is unfamiliar to most patients and may seem frightening. To easy their journey, bestselling author and physician Dr. Rich Snyder has written What You Must Know About Liver Disease, a guide to understanding the disease and its treatment options. The... View Details
Dr. Melissa Palmer's Guide To Hepatitis and Liver Disease: A Practical Guide to Understanding, Treating & Living with Hepatitis & Liver
by Melissa Palmer (Author)
In the United States alone, more than four million people are infected with the hepatitis C virus, and chronic liver disease is the twelfth leading cause of death. In this revised and updated edition of her groundbreaking 2000 book, renowned hepatologist Dr. Melissa Palmer discusses all facets of liver disease, from symptoms and tests to treatment options and lifestyle changes. In addition, this comprehensive handbook reveals cutting-edge research on the dangers of hepatitis C, one of the world's fasting-growing microbial threats. View Details
Sleisenger and Fordtran's Gastrointestinal and Liver Disease- 2 Volume Set: Pathophysiology, Diagnosis, Management, 10e (Gastrointestinal & Liver Disease (Sleisinger/Fordtran))
by Mark Feldman MD (Author), Lawrence S. Friedman MD (Author), Lawrence J. Brandt MD (Author)
Now in its 10th edition, Sleisenger and Fordtrans Gastrointestinal and Liver Disease remains your indispensable source for definitive, state-of-the-art answers on every aspect of gastroenterology and hepatology. Overcome your most complex clinical challenges and make optimal use of the newest techniques, technologies, and treatmentswith superb guidance from hundreds of world-renowned authorities. Meticulous updates throughout include the latest approaches and improvements in gastrointestinal and liver disease diagnosis and therapy as well as hundreds of images and 35 new procedural... View Details
Fatty Liver: The Ultimate Step-by-Step Guide To Understanding and Reversing Fatty Liver Disease (Liver Cleanse, Nutrition, Liver Cleanse, Healthy Living, Revitalise Health, Detox Body, Weight)
by Henry Thompson (Author)
Learn To Understand and Reverse Fatty Liver Disease With This Easy Step-By-Step Guide! Do you want a guide on Fatty Liver that teaches you to understand and reverse the disease? Do you want to learn about Fatty Liver Disease in a style and approach that is suitable for you, regardless of your experience? This book not only provides step-by-step instructions to some of the basic ideas of Fatty Liver Disease you will need, it gives suggestions for reversing it and step-by-step Meal Plans! Are you ready to learn? If so, Fatty Liver Disease: The Ultimate Step-by-Step... View Details